Please login to the form below
Zevtera
This page shows the latest Zevtera news and features for those working in and with pharma, biotech and healthcare.
Basilea moves closer to US filing of novel antibiotic
Ceftobiprole is already marketed as Zevtera and Mabelio for hospital and community-acquired pneumonia (HAP and CAP) in Europe and other ex-US markets through multiple partner companies.
Latest news
-
Basilea bags $72m upfront from Pfizer for antifungal license
Basilea launched the antifungal in its first European markets last year - Austria, France, Germany, Italy and the UK - with combined sales of the antifungal and new antibiotic Zevtera (ceftobiprole) reaching ... Meanwhile, Basilea says it is still on the
-
Basilea’s novel antibiotic reaches UK market
Swiss biopharma company Basilea has launched its new cephalosporin antibiotic Zevtera in the UK, the latest market in its European roll-out for the drug. ... The launch of Zevtera in Europe is being supported by Quintiles' commercial services unit under
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Latest appointments
-
Basilea appoints commercial head
Ronald Scott, CEO of Basilea, commented that Veitch's “extensive experience and in-depth knowledge of European pharmaceutical markets will be instrumental” as the company prepares to launch its antibiotic Zevtera
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- World AIDS Day 35: Medscape’s Commitment to the Elimination of HIV through Education and Looking Towards the Future
- No “White Space” Between Live Meetings; the top 10 benefits of virtual advisory boards
- Building trust with HCPs: 6 takeaways from our industry webinar
- Eli Lilly and PRISM BioLab enter drug discovery collaboration worth over $660m
- NHS to offer stem cell transplants to patients living with rare blood disorder
- First WHO Global Clinical Trial Forum develops joint vision to improve clinical research
No results were found
PMHub
Cuttsy + Cuttsy
Here at Cuttsy+Cuttsy, we believe in making the world a better place by bringing trusted, accessible information to all and...
Latest intelligence
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
- The rise of digital healthcare – fuelled by open innovation in healthtech hubs
- How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...
